SLC16A1 Gene Hyperinsulinemic Hypoglycemia Type 7 Genetic Test sale cost 4400 AED
CETP Gene Hyperalphalipoproteinemia Genetic Test sale cost 4400 AED CETP Gene Hyperalphalipoproteinemia Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
PTS Gene Hyperphenylalaninemia BH4-Deficient Type A Genetic Test sale cost 4400 AED PTS Gene Hyperphenylalaninemia BH4-Deficient Type A Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

SLC16A1 Gene Hyperinsulinemic Hypoglycemia Type 7 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The SLC16A1 gene hyperinsulinemic hypoglycemia type 7 genetic test is a specialized diagnostic examination designed to identify mutations in the SLC16A1 gene, which are linked to a rare form of congenital hyperinsulinemic hypoglycemia. This condition is characterized by excessive insulin production leading to dangerously low blood sugar levels. The test is crucial for the early detection and management of this disorder, enabling healthcare providers to tailor appropriate treatment plans for affected individuals.

Performed at DNA Labs UAE, a leading facility in genetic diagnostics, this test involves collecting a DNA sample, typically through a blood draw, from the patient. The sample is then analyzed using advanced genetic sequencing technologies to detect any abnormalities in the SLC16A1 gene that may be responsible for the condition.

The cost of the SLC16A1 gene hyperinsulinemic hypoglycemia type 7 genetic test at DNA Labs UAE is set at 4400 AED. This price reflects the sophisticated nature of the testing process and the specialized expertise required to accurately interpret the results. For families and individuals facing the possibility of this rare genetic disorder, this test represents a critical step towards understanding and managing the condition effectively.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

SLC16A1 Gene Hyperinsulinemic hypoglycemia type 7 Genetic Test

Test Name: SLC16A1 Gene Hyperinsulinemic hypoglycemia type 7 Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Metabolic Disorders

Doctor: General Physician

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for SLC16A1 Gene Hyperinsulinemic hypoglycemia type 7 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with Hyperinsulinemic hypoglycemia type 7.

Test Details

The SLC16A1 gene is responsible for producing a protein called monocarboxylate transporter 1 (MCT1), which is involved in transporting certain molecules, including lactate and pyruvate, across cell membranes. Mutations in the SLC16A1 gene can lead to a condition known as hyperinsulinemic hypoglycemia type 7.

Hyperinsulinemic hypoglycemia refers to a condition characterized by abnormally high levels of insulin in the blood, leading to low blood sugar levels (hypoglycemia). In type 7, the condition is caused by mutations in the SLC16A1 gene, which disrupt the normal function of MCT1. This can result in excessive insulin secretion by the pancreas, leading to hypoglycemia.

NGS (Next-Generation Sequencing) genetic testing refers to a type of genetic testing that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the case of hyperinsulinemic hypoglycemia type 7, NGS genetic testing can be used to identify mutations in the SLC16A1 gene that may be responsible for the condition.

By identifying specific mutations in the SLC16A1 gene, NGS genetic testing can help diagnose hyperinsulinemic hypoglycemia type 7 and guide appropriate treatment options. Treatment for this condition typically involves managing blood sugar levels through dietary modifications, medication, and in some cases, surgical intervention.

Test Name SLC16A1 Gene Hyperinsulinemic hypoglycemia type 7 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Metabolic Disorders
Doctor General Physician
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for SLC16A1 Gene Hyperinsulinemic hypoglycemia type 7 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Hyperinsulinemic hypoglycemia type 7
Test Details

The SLC16A1 gene is responsible for producing a protein called monocarboxylate transporter 1 (MCT1), which is involved in transporting certain molecules, including lactate and pyruvate, across cell membranes. Mutations in the SLC16A1 gene can lead to a condition known as hyperinsulinemic hypoglycemia type 7.

Hyperinsulinemic hypoglycemia refers to a condition characterized by abnormally high levels of insulin in the blood, leading to low blood sugar levels (hypoglycemia). In type 7, the condition is caused by mutations in the SLC16A1 gene, which disrupt the normal function of MCT1. This can result in excessive insulin secretion by the pancreas, leading to hypoglycemia.

NGS (Next-Generation Sequencing) genetic testing refers to a type of genetic testing that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the case of hyperinsulinemic hypoglycemia type 7, NGS genetic testing can be used to identify mutations in the SLC16A1 gene that may be responsible for the condition.

By identifying specific mutations in the SLC16A1 gene, NGS genetic testing can help diagnose hyperinsulinemic hypoglycemia type 7 and guide appropriate treatment options. Treatment for this condition typically involves managing blood sugar levels through dietary modifications, medication, and in some cases, surgical intervention.

SKU: TEST-2443